lymphoblastic lymphoma
Showing 1 - 25 of 52
Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)
Recruiting
- Lymphoblastic Lymphoma
- +2 more
- BEAM-201
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 2, 2023
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
Associated With Cardiomyopathy and Heart Failure After Cancer
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
-
Birmingham, Alabama
- +78 more
Jan 11, 2023
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,
Active, not recruiting
- Acute Biphenotypic Leukemia
- +18 more
- Cyclophosphamide
- +8 more
-
Aurora, Colorado
- +2 more
Dec 28, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Letermovir
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +5 more
- Biospecimen Collection
- +4 more
- (no location specified)
Oct 28, 2022
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)
Recruiting
- Acute Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 26, 2022
Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (Everolimus, Nelarabine, Cyclophosphamide)
Recruiting
- Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Everolimus
- +3 more
-
Atlanta, Georgia
- +3 more
Aug 18, 2022
Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Tumors Trial in Frankfurt (Adriamycin, Cyclophosphamide, Cytarabine)
Completed
- Burkitt's Lymphoma
- +4 more
- Adriamycin
- +10 more
-
Frankfurt, GermanyUniversity Hospital, Medical Dept. II
Aug 17, 2022
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Duarte (Best Practice, Internet-Based
Recruiting
- Acute Leukemia
- +3 more
- Best Practice
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)
Not yet recruiting
- Hematologic Malignancy
- +10 more
- Tagraxofusp
- +8 more
-
Los Angeles, California
- +28 more
Jul 26, 2022
Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,
Recruiting
- Leukemia, Acute Lymphoblastic
- +5 more
- Fludarabine
- +5 more
-
Saint Petersburg, Russian FederationRM Gorbacheva Research Institute
Jul 19, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Cyclophosphamide
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 18, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)
Recruiting
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Rituximab
- +18 more
-
Frankfurt (Main), GermanyUniversity Hospital of Frankfurt (Main)
Jul 1, 2022
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Australia, United States (WU-CART-007)
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- WU-CART-007
-
Duarte, California
- +7 more
Jun 22, 2022
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with
Recruiting
- Acute Leukemia
- +27 more
- HSCT with TBI Regimen
- HSCT with Non-TBI Regimen
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and
Recruiting
- Acute Leukemia
- +7 more
- CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 21, 2022
Lymphoblastic Lymphoma Trial in Chengdu, Shanghai (Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide,
Active, not recruiting
- Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine
- +6 more
-
Chengdu, China
- +1 more
Mar 17, 2022
Questionnaire and Tissue Banking For Multiple Myeloma,
Active, not recruiting
- Multiple Myeloma
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 15, 2022
Leukemia, Lymphocytic, Lymphoblastic Lymphoma, T-cell Lymphoma Trial in United States (Palbociclib, Cytarabine, Methotrexate)
Active, not recruiting
- Leukemia, Lymphocytic
- +5 more
- Palbociclib
- +8 more
-
Birmingham, Alabama
- +18 more
Feb 25, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
Recruiting
- Lymphoblastic Lymphoma
-
Oviedo, Asturias, Spain
- +27 more
Jan 31, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +4 more
-
Valhalla, New York
- +1 more
Oct 29, 2021
Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Trial in Australia, United States (Navitoclax, Chemotherapy,
Completed
- Acute Lymphoblastic Leukemia (ALL)
- Lymphoblastic Lymphoma
- Navitoclax
- +2 more
-
Duarte, California
- +14 more
Oct 7, 2021